Skip to main content

09-03-2019 | Medications | News

News in brief

Diabetes medications need review ahead of weight-loss interventions


medwireNews: The specific medications people are taking for diabetes can affect their success when they undertake a weight-loss program, say researchers.

Although people lost weight, on average, regardless of which medications they were taking, those taking medications that promote weight loss or have a neutral effect lost an average of 3.3 kg whereas those taking medications known to promote weight gain lost a significantly smaller 2.5 kg.

The study from Jennifer Logue (University of Glasgow College of Medical Veterinary and Life Sciences, UK) and team involved 998 people with type 2 diabetes who attended at least two sessions of a local weight management service.

The team regarded metformin, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium-glucose cotransporter 2 inhibitors as weight neutral or promoting loss. Sulfonylureas, thiazolidinediones, and insulin were grouped as promoting weight gain.

“Although those prescribed weight-neutral medications had a higher BMI on average than those on weight-gaining medications, there were many participants prescribed weight-gaining medications that were deemed in need of weight management,” write the researchers in Diabetic Medicine.

“Ensuring that people are prescribed appropriate diabetes medications at the time of referral to a lifestyle weight management programme may help maximize the success of the intervention.”

By Eleanor McDermid

medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group

Diabet Med 2019; doi:10.1111/dme.14093


New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

GLP-1 receptor agonists

Browse the latest news, clinical trial updates, and expert commentary.